Abstract:Background: Currently, drugs for local bone formation are very limited in clinic. Simvastatin is one of most potential translational drugs by repositioning for its significant osteogenic effect and its history as a safe lipid-lowering medicine. In this study, we prepared the pre-clinical simvastatin microcrystals which could be potentially translated and industrialized. Methods: Simvastatin microcrystals were made by wet media milling method. Characterization of microcrystal particles were evaluated by laser particle size analyzer and high-performance liquid chromatography (HPLC). Furthermore, we verified the osteogenic effect in rat ovariectomy(OVX)-induced osteoporosis model and femur defect model. For osteoporosis model, we delivered simvastatin microcrystals to tibia with poloxamer hydrogel by intraosseous injection. Bone mineral density (BMD) and ultimate force were assessed after treatment. For femur defect model, simvastatin microcrystal was incorporated in clinically used calcium phosphate cements (CPCs) as an implant. Histology and μCT were used for evaluation of the healing. Results: The D 10 , D 50, and D 90 showed size of the most particles ranged from 0.226-3.425 μm. The mean particle size of the microcrystals is determined as 1.365 μm which demonstrated a successful preparation. For osteoporosis model, BMD and the ultimate force of the treated tibia were significantly improved in osteoporosis rat after injection of 0.5 mg and 1 mg simvastatin microcrystals compared with OVX or 0 mg groups. There were no differences observed in BMD and ultimate force between 0.5 mg, 1 mg simvastatin microcrystals group and bone morphogenetic protein (BMP) 5 ug group. For femur defect model, quantitative analysis of bone regeneration by μCT showed bone volume/tissue volume (BV/TV), trabecular thickness (Tb.Th), trabecular number (Tb.N) were significantly increased in simvastatin microcrystals 50ug (SIM-C 50 ug), SIM-C 100 ug and BMP 5 ug group compared with CPC vehicle group. Trabecular separation (Tb.Sp), and cement volume/tissue volume (CV/TV) were decreased in SIM-C 50 ug, SIM-C 100 ug and BMP 5 ug groups compared with CPC vehicle group. Semiquantitative scale for histology assessment further demonstrated a higher bone regeneration score in drug loaded groups compared with CPC group.Conclusions: Our study shows that simvastatin microcrystals were successfully prepared by wet media milling method and the microcrystals can promote bone formation by local delivery by poloxamer hydrogel or CPC, which is of great translational potential.

The effect of simvastatin on chemotactic capability of SDF-1α and the promotion of bone regeneration.

Mesenchymal Stem Cell Sheet Transplantation Combined with Locally Released Simvastatin Enhances Bone Formation in a Rat Tibia Osteotomy Model.

[Ectopic Osteogenesis of Stromal Cell-Derived Factor 1 Combined with Simvastatin-Loaded Collagen Scaffold in Vivo].

Calvarial Defect Healing by Recruitment of Autogenous Osteogenic Stem Cells Using Locally Applied Simvastatin.

[Experimental study of tissue-engineered bone constructed with simvastatin carried by PLGA/CPC and bone marrow stromal cells]

Effects of Simvastatin on the Osteogenic Differentiation and Immunomodulation of Bone Marrow Mesenchymal Stem Cells.

Locally applied simvastatin recruits bone marrow stromal cells to repair rat calvarial defect

Enhanced osteogenesis and angiogenesis by mesoporous hydroxyapatite microspheres-derived simvastatin sustained release system for superior bone regeneration

Simvastatin-loaded Porous Implant Surfaces Stimulate Preosteoblasts Differentiation: an in Vitro Study.

[Effect of Simvastatin on Inducing Endothelial Progenitor Cells Homing and Promoting Bone Defect Repair].

Enhancement of Osteoinduction by Continual Simvastatin Release from Poly(lactic-co-glycolic Acid)-Hydroxyapatite-simvastatin Nano-Fibrous Scaffold

The Role of Simvastatin in the Osteogenesis of Injectable Tissue-Engineered Bone Based on Human Adipose-Derived Stromal Cells and Platelet-Rich Plasma

Mineralised Collagen Scaffolds Loaded with Stromal Cell-derived Factor-1 Improve Mandibular Bone Regeneration.

Human Adipose-Derived Stem Cells and Simvastatin-Functionalized Biomimetic Calcium Phosphate to Construct a Novel Tissue-Engineered Bone.

Simvastatin Nano Hydroxyapatite Scaffold on the Restoration of Mandible Defect

[Repair of Calvarial Defect Using a Tissue-Engineered Bone with Simvastatin-Loaded Β-Tricalcium Phosphate Scaffold and Adipose Derived Stem Cells in Rabbits].

Biocompatibility and osteogenesis of calcium phosphate composite scaffolds containing simvastatin-loaded PLGA microspheres for bone tissue engineering

The Effect of Topical Administration of Simvastatin on Entochondrostosis and Intramembranous Ossification: an Animal Experiment.

Simvastatin Enhances the Chondrogenesis But Not the Osteogenesis of Adipose-Derived Stem Cells in a Hyaluronan Microenvironment

Osteogenic effect in rat osteoporosis model and femur defect model by intraosseous administration of simvastatin microcrystals

Combination of Simvastatin, Calcium Silicate/gypsum, and Gelatin and Bone Regeneration in Rabbit Calvarial Defects